October 15, 2014 20:12 (IST)
Elder Pharmaceuticals on Wednesday said it has entered into fast-growing Rs 600-crore Indian mouthwash category in the oral care segment where the company is eyeing 5-7 per cent share in the next few years.
October 13, 2014 20:16 (IST)
Drug major Novartis has been slapped with a Rs 300 crore penalty by the National Pharmaceutical Pricing Authority (NPPA) for overcharging consumers on sale of Voveran, its best-selling painkiller.
October 12, 2014 18:24 (IST)
For the July-September period, we expect a robust growth of 18 per cent in revenues, EBITDA 22 per cent and earnings 18 per cent for our coverage universe, driven by ramp-up in the US and steady growth in India due to price hikes for certain products," Edelweiss Securities said in its report here.
October 09, 2014 22:49 (IST)
The Centre's decision to decontrol prices of 108 cardiac and diabetes drugs was on Thsrday challenged before the Supreme Court which agreed to hear the case "as soon as possible".
October 09, 2014 22:38 (IST)
Indian pharmaceutical companies need to focus on the Latin American markets namely Brazil and Mexico, British brokerage firm Barclays has said.
October 08, 2014 22:59 (IST)
India's pharma majors Dr Reddy's and Sun Pharma are among 14 drug makers which are being probed by the US Congress over price escalation of generic drugs.
October 07, 2014 16:18 (IST)
Cipla, which will own 75 per cent stake in the plant being set up in partnership with its local distributor, will invest about Rs 225 crore ($36.65 million) over three years on areas including machinery and equipment for the facility.
October 05, 2014 19:37 (IST)
India's over the counter (OTC) drug market is expected to grow to $6.6 billion by 2016 with pharmaceutical companies and chemists increasing their presence in the rural market.
October 04, 2014 17:14 (IST)
Drug major Cipla has signed an agreement with its Iranian distributor for setting up a manufacturing unit in that country.
October 01, 2014 20:53 (IST)
Drug firm Ranbaxy Laboratories on Wednesday launched a capsule used for treatment of severe acne in the US.
October 01, 2014 11:00 (IST)
Analysts say Apollo would benefit by potentially attracting more patients to its main hospitals.
September 30, 2014 22:58 (IST)
The Delhi High Court on Tuesday asked the National Pharmaceutical Pricing Authority (NPPA) to show the manner in which it is exercising its power to cap prices of non-scheduled drugs in view of the recent withdrawal of the guidelines issued for the purpose.
September 29, 2014 22:50 (IST)
Drug maker Sun Pharma has said that it will take a "few years" for it to realise the benefits of its $4-billion takeover of Ranbaxy, terming the deal as a "complex and large acquisition".
September 29, 2014 15:41 (IST)
Biotech medicines - made from proteins and other large molecules - account for six of the 10 biggest-selling drugs in the world today, led by AbbVie's $12 billion-a-year rheumatoid arthritis injection Humira.
September 29, 2014 14:06 (IST)
Sun Pharma and Ranbaxy Lab rallied around 4 per cent to Rs 839.80 and Rs 627.40 respectively, whereas Glenmark Pharmaceuticals and Aurobindo Pharma were up between 4-6 per cent.
September 24, 2014 11:12 (IST)
NPPA had capped prices of 108 non-essential drugs in July to improve its affordability, but the decision was greeted with protests and has been challenged in courts in India as prices of generic drugs are already low in India compared with other markets.
September 23, 2014 11:10 (IST)
The National Pharmaceutical Pricing Authority (NPPA) said the government has withdrawn its power to set prices of nonessential medicines, but price caps on over 100 non-essential drugs that drew the industry's ire in July will remain.
September 22, 2014 23:11 (IST)
German drug maker Merck KGaA will acquire US-based Sigma-Aldrich, led by Indian-origin CEO Rakesh Sachdev, for $17 billion in an all cash deal.
September 19, 2014 19:18 (IST)
China fined GlaxoSmithKline Plc a record 3 billion yuan ($490 million) on Friday for paying bribes to doctors to use its drugs, underlining the risks of doing business there while also ending a damaging chapter for the British drug maker.
September 19, 2014 16:26 (IST)
Drugmakers, including Cipla Ltd, Ranbaxy Laboratories Ltd, and Cadila Healthcare Ltd are among the companies that will be affected by the latest decision, research firm AIOCD Pharmasofttech AWACS Pvt Ltd said.